
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
RECENT TREATMENT OF MUCORMYCOSIS – A REVIEW
Aditi Sanap*, Sujata Lambe, Saurabh Kadbhane, Vishal Chavan and Amol Barhe
. Abstract Mucormycosis is triggered by hyaline moulds, which are recognized as Mucorales in the Mucoromycotina, a subphylum of lower fungi. Black Fungus is another name for it. Mucorels is made up of 11 genera and 27 species, all of which have been connected to human disorders. Rhizopus arrhizus is the most prevalent cause of Mucormycosis, followed by Apophysomyces, Lichtheimia, Rhizomucor, Mucor, and Cunninghamella species. The illness produced by these fungi was described as zygomycosis, Mucormycosis, a well-known name in clinical medicine, is an acceptable term to use when referring to the disease caused by fungus.[1,2,3] Keywords: . [Full Text Article] [Download Certificate] |
